Ketone drink study for alcohol use disorder brain function
Part of Mental health clinical trials.
This study tests whether a ketone-based treatment (a ketone ester) can change brain activity in people with alcohol use disorder who are not currently seeking treatment. You may also have brain scans, so the study is looking for safe MRI eligibility and certain health factors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 21 and 65 years old
- Have a diagnosis of alcohol use disorder (AUD) based on DSM-5 criteria
- Typically drink at least 15 standard drinks per week in the past month
- Not be actively seeking treatment for alcohol problems right now
- Choose alcohol as your main drug of concern (not another preferred drug)
- Be able to safely do MRI scans (including no metal/unsafe implants and able to lie flat)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if taking a ketone supplement can reduce alcohol cravings and drinking in people with mild to moderate alcohol use disorder who are not currently seeking treatment. You will have MRI scans, PET scans, and supervised drinking sessions to see how the supplement affects your brain and alcohol intake.
This study tests whether a special ketone drink can ease alcohol withdrawal and help your brain heal. If you have been drinking heavily for at least 3 years and are having withdrawal symptoms now, this might be an option for you.
This study uses special brain and heart scans to see how sugar (glucose) is used in people with alcohol use disorder compared with people without it. It may help researchers understand the brain–heart connection in alcohol use disorder.
This study looks at how a ketone supplement and alcohol affect your brain's metabolism. You will be asked to visit the lab, have an MRI, and possibly take the supplement or drink alcohol.
This trial tests how the medication acamprosate affects brain activity in people with moderate to severe alcohol use disorder. It may help researchers understand how this treatment works.
This study uses a special brain scan (PET) to look at a protein called PDE4B in people with alcohol use disorder. The goal is to better understand how alcohol affects the brain, which may lead to new treatments.
Hear when a new Alcohol Drinking trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.